Quillivant XR clinical study results

A clinical study demonstrated that children who took Quillivant XR® (methylphenidate HCl) had improved attention and behavior when compared to those who took a sugar pill.

The study was performed in a laboratory classroom setting. At the end of each week, teachers and raters used a rating scale (SKAMP) to evaluate the efficacy of Quillivant XR on attention and behavior in children with ADHD ages 6 to 12 when compared to children taking a sugar pill.

Children taking Quillivant XR showed improved attention and behavior from 45 minutes to 12 hours after taking when compared with those children who took sugar pills.

In a clinical study performed in a laboratory classroom, Quillivant XR was found effective at reducing the symptoms of ADHD in children ages 6-12 years at all measured times (45 minutes, 2, 4 [primary endpoint], 8, 10, and 12 hours after taking) compared to a sugar pill.